CPC A61K 31/519 (2013.01) [A61K 47/40 (2013.01); A61K 9/0051 (2013.01); A61K 9/19 (2013.01)] | 9 Claims |
1. A method of treating or ameliorating retinal degeneration in a subject,
the method comprising administering topically to the eye of the subject an ophthalmologically acceptable pharmaceutical composition comprising ciclopirox (6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone), or a salt or solvate thereof, and at least one compound selected from the group consisting of hydroxypropyl-alpha-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
|